A&P
Patent reexamination counsel·3 ex parte reexams
A&P has served as patent-owner counsel in 3 USPTO ex parte reexaminations. The firm most often represents Regeneron Pharmaceuticals Inc. and Cable Television Laboratories Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top patent owners represented
Outcome track record
How this firm's reexams resolve once a certificate issues: all claims confirmed, amended, mixed, or canceled.
- Certificate outcome split across every bucket
- Share of proceedings where claims survived
Practice metrics
Certificate rate, average pendency, and the open/closed split across the firm's full reexam docket.
- Certificate rate of closed proceedings
- Average pendency in months
Examiners & adversaries
Which examiners most often decide this firm's reexams, and which requesters most often challenge its patents.
- Most frequent examiners
- Top opposing requesters
Recent reexaminations (3)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/014,708 | Mar 23, 2021 | 5,815,488 | Multiple User Access Method Using OFDM | Cable Television Laboratories Inc. | Closed |
| 90/014,449 | Feb 11, 2020 | 10,406,226 | METHOD OF MANUFACTURING VEGF ANTAGONIST FUSION PROTEINS | Regeneron Pharmaceuticals Inc. | Closed |
| 90/014,448 | Feb 11, 2020 | 10,464,992 | VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION | Regeneron Pharmaceuticals Inc. | Closed |
Other reexam law firms
See the full reexam picture for A&P
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.